SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
4 references·5 citing·33 second hop
A systematic review of cost-effectiveness analyses of pharmacogenomic interventions (2004)A systematic review of cost-effectiveness…HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis (2004)HER-2 Testing and Trastuzumab…Searching Literature Databases for Health Care Economic Evaluations (2002)Searching Literature Database…Passing the baton (2002)Passing the batonCost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …The economic case for precision medicine (2018)The economic case for precisi…Is Individualized Medicine More Cost-Effective? A Systematic Review (2014)Is Individualized Medicine Mo…Current Methodological Issues in the Economic Assessment of Personalized Medicine (2013)Current Methodological Issues…Clinical and economic challenges facing pharmacogenomics (2012)Clinical and economic challen…Economic Opportunities and Challenges for Pharmacogenomics (2010)Economic Opportunities and Ch…Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment (2007)Does Comparative-Effectiveness Research Threaten Personalized Medicine? (2009)Personalized medicine: Factors influencing reimbursement (2009)Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options (2022)Developing Optimal Search Strategies for Detecting Clinically Sound Studies in MEDLINE (1994)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Evaluating the BMJ Guidelines for Economic Submissions (1998)Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Cost-Effectiveness Analyses of Vaccination Programmes (2008)How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) (2016)Methods for the Economic Evaluation of Health Care Programmes (2005)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Methods for the economic evaluation of health care programmes, 3rd ed (2006)Decision Support for Re-Designed Medicinal Products - Assessing Consequences of a Customizable Product Design on the Value Chain from a Sustainability Perspective (2019)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu–Positive Breast Cancer (2007)Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (2007)Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer (2007)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The price of innovation: new estimates of drug development costs (2003)Can the pharmaceutical industry reduce attrition rates? (2004)National Institute for Clinical Excellence and its value judgments (2004)Valuing the ICECAP capability index for older people (2008)Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions (2018)Methods for the economic evaluation of health care programmes (1987)Decision Modelling For Health Economic Evaluation (2006)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods (2005)Monetary valuation of informal care: the well‐being valuation method (2007)Well-being losses due to care-giving (2014)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2004HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis230 cited
  • 2002Searching Literature Databases for Health Care Economic Evaluations73 cited
  • 2002Passing the baton64 cited

Cited by

  • 2013Current Methodological Issues in the Economic Assessment of Personalized Medicine93 cited
  • 2018The economic case for precision medicine93 cited
  • 2014Is Individualized Medicine More Cost-Effective? A Systematic Review74 cited
  • 2012Clinical and economic challenges facing pharmacogenomics70 cited
  • 2010Economic Opportunities and Challenges for Pharmacogenomics60 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work